Vandetanib: in medullary thyroid cancer. [electronic resource]
Producer: 20121203Description: 1423-36 p. digitalISSN:- 1179-1950
- Administration, Oral
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Neuroendocrine
- Disease-Free Survival
- Humans
- Molecular Structure
- Neoplasm Metastasis
- Piperidines -- administration & dosage
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Quinazolines -- administration & dosage
- Randomized Controlled Trials as Topic
- Thyroid Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.